Lens tissue transcriptome analysis in patients with total congenital cataract Authors: Xiaolei Lin, Huiyu Chen, Xin Liu, Fan Fan, Yulan Wang, Yi Luo Published: 2026 ABSTRACT BackgroundTotal congenital cataract (TCC), a leading cause of childhood visual impairment. We analyzed transcriptome profiles of lens epithelial cells (LECs) and lens fiber cells (LFCs) in pediatric patients with TCC to identify differentially expressed genes (DEGs) and potential pathogenic pathways.ResultsIn LECs, 1,645 DEGs were identified, enriched in structural constituents of the eye lens extracellular matrix component and extracellular matrix organization. LFCs exhibited 2,708 DEGs, enriched in SRP-dependent cotranslational protein targeting to membrane, protein targeting to ER, and cotranslational protein targeting to membrane. Cross-referencing with iSyTE2.0 highlighted HOPX, SUSD2, SH3BGR, BIRC7, and GSS as top candidates. All five candidate genes were significantly downregulated in both LECs and LFCs that were lens-enriched genes during embryonic development.ConclusionsThis study reveals distinct transcriptomic profiles in LECs and LFCs of TCC patients, implicating novel genes in lens development, oxidative stress, and apoptosis.Supplementary InformationThe online version contains supplementary material available at 10.1186/s40246-026-00993-0. Background Congenital cataract, the primary cause of childhood blindness, disrupts visual development and leads to irreversible deficits. Despite surgical advances, treatment remains challenging and costly, underscoring the need to elucidate pathogenesis for early intervention [1, 2]. Total congenital cataract (TCC), accounting for 31.2% of all congenital cataract cases, is one of the most common types and causes severe stimulus deprivation amblyopia and visual impairment [3]. Previous studies found that TCC is primarily caused by mutations in crystalline genes (e.g., CRYAA [4], CRYGC [5], CRYGD [6]), the cytoskeleton gene (BFSP2), connexin and signaling genes (GJA3 [7], GJA8 [8], MIP [6], EZR [9]), followed by transcription factors (HSF4 [10], MAF [11] and homeobox genes [12] (PAX6 [12, 13], PITX3 [12, 14])) and metabolism-related genes (WFS1 [15], GCNT1 [6], EPHA2 [16], LSS [2]). These mutations disrupt lens protein structure, intercellular communication, developmental regulation, metabolic balance, and ultimately leading to complete lens opacification. These genes provide excellent candidates for etiological research, genetic counseling, prenatal diagnosis, and potential gene therapy. However, the abovementioned studies have used peripheral blood as the sequencing tissue, which is more suitable for detecting pathogenic mutations of germline origin that are present in all cells of the body. Its ability to detect conditions such as somatic mosaicism, tissue-specific mutations, mitochondrial heteroplasmy, dynamic mutations, and epigenetic abnormalities is limited [17, 18]. RNA-seq of specific tissues can provide tissue-specific gene expression information, which plays a crucial role in identifying candidate genes associated with ocular developmental defects. Previous studies have performed tissue RNA-seq on the lenses of mice at different embryonic developmental stages and established the iSyTE 2.0 database, which is currently the only gene expression database related to lens development and holds important reference value [19]. RNA-seq was also conducted on the lens tissues of PROX1 and Mettl3 knockout mice to explore the regulatory effect of the PROX1 and Mettl3 genes on lens development [20, 21]. However, there are no reported studies on RNA-seq of lens tissues from human patients with TCC to date. In this study, lens epithelial cells (LECs) and lens fiber cells (LFCs) were collected from four patients with TCC and four normal controls. We compare mRNA profiles in lens epithelial and fiber cells between patients and controls, integrating bioinformatic analyses and RT-qPCR validation to uncover novel mechanisms. Methods Study subjects The Investigational Review Board of the Eye and ENT Hospital at Fudan University, Shanghai, China (protocol code: 2020076), approved this study, which was carried out strictly in accordance with the guidelines set forth in the Helsinki Declaration. Legal guardians provided written informed consent. Pediatric patients under 10 years of age with unilateral/bilateral TCC were included in the study. Exclusion criteria comprised ocular surgery/trauma, pre-existing posterior capsule deficits, persistent hyperplastic primary vitreous, persistent fetal vasculature, ocular inflammation, and other developmental abnormalities. The control group consisted of transparent lenses from children under 10 years of age obtained through the Eye Bank of the Eye and ENT Hospital of Fudan University within 24 h post-mortem. For RNA-seq and RT-qPCR validation, lens tissue from patients and controls was collected. Anterior capsules and cortical/nuclear fibers were isolated during surgery or post-mortem. In TCC patients, the anterior lens capsules (with attached epithelial cells) were manually peeled off by continuous curvilinear capsulorhexis, while cortical and nuclear lens fibers were collected by sterile and manual aspiration separately, with sterile BSS rinsing to avoid cross-contamination during cataract surgery by the same surgeon (Y.L.). Lens anterior capsules were immediately stored in a −80 °C freezer. Lens fiber samples were centrifuged at 4 °C and 2000 rpm for 5 min. The supernatant was discarded, and the pellet was retained and immediately stored in a −80 °C freezer. RNA extraction, library construction, and sequencing Total RNA was isolated using the Quick-RNA™ Microprep Kit (Zymo Research, Orange, CA, USA). RNA quality was assessed via Qubit 4.0 fluorometry and agarose gel electrophoresis. Library purification was performed using DNA Clean Magnetic Beads (Vazyme), with quality assessment conducted via 2% agarose gel electrophoresis (Thermo Fisher Scientific, Waltham, MA, USA). Validated libraries underwent high-throughput sequencing on the Illumina NovaSeq 6000 platform (Illumina Inc., San Diego, CA, USA). Bioinformatic analysis Reads were aligned to GRCh38 using STAR (v2.5.3a). Gene counts were quantified with StringTie (v1.3.1c) and normalized to fragments per kilobase of transcript per million mapped reads (FPKM). Differential gene expression between patient and control cohorts was assessed through the DESeq2 algorithm (v1.16.1). DEGs were classified as genes with |log₂ Fold Change| > 1 and P < 0.05. The false discovery rate (FDR) for multiple testing was managed using the Benjamini-Hochberg technique. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and PPI networks (STRING) were analyzed. To determine the main biological roles of DEGs, GO enrichment analysis was carried out using TopGO software (version 2.42.0). To clarify molecular network information, KEGG pathway analysis was carried out utilizing the KEGG database (http://www.genome.jp, accessed on January 23, 2021). Candidate genes were filtered using iSyTE2.0 and Cat-Map databases. RT-qPCR validation TRIzol reagent (Invitrogen, Waltham, MA, USA) was used to extract total RNA from lens tissues, and the PrimeScriptTM RT reagent Kit with gDNA Eraser (TaKaRa, Tokyo, Japan) was used to transform the RNA into cDNA. RT-qPCR was carried out using the Bio-Rad CFX96 Touch Real-Time PCR Detection System with software v4.1 (Bio-Rad, Hercules, CA, USA) using the SYBR® Green Premix Pro Taq HS qPCR Kit (AG11705, Accurate Biotechnology, Changsha, Hunan, China). Table S1 contains a list of RT-qPCR primers specific to each gene. For every biological sample, three technical replicates were conducted. GAPDH served as a normalization internal control. The 2⁻ΔΔCt technique was used to examine the results. Statistical analysis DESeq2 was used to assess differential expression statistics, and the Benjamini-Hochberg multiple test correction method was used to compute corrected P-values. P < 0.05 indicated that the KEGG pathways and GO keywords were considerably enriched. SPSS 22.0 was used to conduct statistical analysis on the RT-qPCR results (IBM, Armonk, NY, USA). Data distribution normality was assessed through the Kolmogorov-Smirnov test. Intergroup comparisons between cataract patients and controls were conducted via the Mann-Whitney U test. The threshold for statistical significance was set at P < 0.05. Results Study population and RNA-seq quality control A total of eight children were included for RNA-seq analysis, comprising four patients with bilateral TCC (age range: 6–14 months) and four normal controls (age range: 7–21 months). Four congenital cataract patients had a negative family history and were non-syndromic. Patient information is detailed in Table S2. Each sample yielded an average of 122,831,609.7 (range: 98,667,040–167,149,114) raw readings. After quality filtering, each sample produced an average of 69,022,055.5 (range: 46,056,324 − 97,071,010) clean readings (Table 1). The percentage of readings aligned with the GRCh38 reference genome ranged from 85% to 95.9%, indicating excellent sequence quality and mapping efficiency. Table 1RNA-seq experimental design, read metrics, and mapped ratiosSampleTissueClean readsClean read-pairsAverage lengthMappedratio (%)CC 1Capsules57,130,76428,565,382146.990%CC 2Capsules97,071,01048,535,50514495.80%CC 3Capsules62,691,09231,345,54614791.10%NC 1Capsules72,896,17236,448,086145.695.90%NC 2Capsules61,877,00630,938,503143.391.90%NC 3Capsules51,813,22625,906,613140.785%NC 4Capsules68,956,75034,478,37514694.30%CC 1Cortex64,198,57632,099,288146.489.40%CC 2Cortex78,979,80239,489,901143.694.60%CC 3Cortex68,237,20034,118,600146.689.60%CC 4Cortex60,060,21030,030,105146.890.20%NC 1Cortex46,056,32423,028,162144.192.60%NC 2Cortex73,789,80436,894,902144.593.80%NC 3Cortex79,457,62039,728,810141.394.80%NC 4Cortex92,115,27646,057,638144.695.40%CC, Congenital cataract, NC, Normal control Table 1RNA-seq experimental design, read metrics, and mapped ratiosSampleTissueClean readsClean read-pairsAverage lengthMappedratio (%)CC 1Capsules57,130,76428,565,382146.990%CC 2Capsules97,071,01048,535,50514495.80%CC 3Capsules62,691,09231,345,54614791.10%NC 1Capsules72,896,17236,448,086145.695.90%NC 2Capsules61,877,00630,938,503143.391.90%NC 3Capsules51,813,22625,906,613140.785%NC 4Capsules68,956,75034,478,37514694.30%CC 1Cortex64,198,57632,099,288146.489.40%CC 2Cortex78,979,80239,489,901143.694.60%CC 3Cortex68,237,20034,118,600146.689.60%CC 4Cortex60,060,21030,030,105146.890.20%NC 1Cortex46,056,32423,028,162144.192.60%NC 2Cortex73,789,80436,894,902144.593.80%NC 3Cortex79,457,62039,728,810141.394.80%NC 4Cortex92,115,27646,057,638144.695.40%CC, Congenital cataract, NC, Normal control RNA-seq experimental design, read metrics, and mapped ratios CC, Congenital cataract, NC, Normal control Differentially expressed genes and functional enrichment analysis in lens epithelial cells There were 1,645 DEGs identified in LECs of TCC patients compared with normal controls, using criteria (|log₂ Fold Change| > 1 and P < 0.05). Among these DEGs, 803 genes were downregulated and 842 genes were significantly upregulated. DEGs were graphically represented through hierarchical clustering heatmaps and volcano plots (Fig. 1B and C). The five most significantly up-regulated and down-regulated DEGs in LECs were shown in Table 2. Fig. 1DEG analysis in lens epithelial cells. (A) DEG analysis workflow. (B) Heatmap of DEGs. (C) Volcano plot results of DEGs. (D) GO enrichment analysis results of DEGs. (E) Expression fold changes in RNA-seq (TCC group relative to the control group), enrichment fold changes in the lens during embryonic development from the iSyTE database, and expression level changes in the lens during embryonic development from the iSyTE database of the top 10 priority candidate genes among DEGs. (F) RT-qPCR validation results DEG analysis in lens epithelial cells. (A) DEG analysis workflow. (B) Heatmap of DEGs. (C) Volcano plot results of DEGs. (D) GO enrichment analysis results of DEGs. (E) Expression fold changes in RNA-seq (TCC group relative to the control group), enrichment fold changes in the lens during embryonic development from the iSyTE database, and expression level changes in the lens during embryonic development from the iSyTE database of the top 10 priority candidate genes among DEGs. (F) RT-qPCR validation results Table 2The five most significantly up-regulated and down-regulated differentially expressed genes in lens epithelial cellsDifferentially expressedSymbolDescriptionLog2(fold change)P valueFDR valueDown-regulatedDDX3YDEAD-box helicase 3, Y-linked−8.045.84E-097.25E-06EIF1AYEukaryotic translation initiation factor 1 A, Y-linked−8.022.00E-068.61E-04RPS4Y1Ribosomal protein S4, Y-linked 1−7.811.50E-067.02E-04HOPXHOP homeobox−6.952.28E-251.98E-21USP9YUbiquitin specific peptidase 9, Y-linked−6.921.21E-081.29E-05Up-regulatedCOL1A2Collagen type I alpha 2 chain5.701.60E-040.02COL1A1Collagen type I alpha 1 chain5.651.13E-040.02KRT14Keratin 145.524.60E-040.05C1QTNF5C1q and TNF related 55.481.55E-081.41E-05FN1Fibronectin 15.261.72E-030.13All expression fold changes were detected in the experimental group relative to the control group Table 2The five most significantly up-regulated and down-regulated differentially expressed genes in lens epithelial cellsDifferentially expressedSymbolDescriptionLog2(fold change)P valueFDR valueDown-regulatedDDX3YDEAD-box helicase 3, Y-linked−8.045.84E-097.25E-06EIF1AYEukaryotic translation initiation factor 1 A, Y-linked−8.022.00E-068.61E-04RPS4Y1Ribosomal protein S4, Y-linked 1−7.811.50E-067.02E-04HOPXHOP homeobox−6.952.28E-251.98E-21USP9YUbiquitin specific peptidase 9, Y-linked−6.921.21E-081.29E-05Up-regulatedCOL1A2Collagen type I alpha 2 chain5.701.60E-040.02COL1A1Collagen type I alpha 1 chain5.651.13E-040.02KRT14Keratin 145.524.60E-040.05C1QTNF5C1q and TNF related 55.481.55E-081.41E-05FN1Fibronectin 15.261.72E-030.13All expression fold changes were detected in the experimental group relative to the control group The five most significantly up-regulated and down-regulated differentially expressed genes in lens epithelial cells All expression fold changes were detected in the experimental group relative to the control group GO annotation revealed significant enrichment of DEGs in several biological functions. The most significantly enriched GO terms included structural constituent of eye lens (P < 0.001), involving BFSP1, BFSP2, CPOX, CRYBA1, CRYBA2, CRYBA4, CRYBB1, CRYBB2, CRYBB3, CRYGB, CRYGD, CRYGS, LIM2, and MIP; extracellular matrix component (P < 0.001), including VWC2, LAMA2, ADGRB3, C1QTNF7, FREM2, TNR, CTHRC1, SMOC2, FN1, C1QTNF5, COL1A1, and COL1A2; and extracellular matrix organization (P < 0.001), comprising OMG, VWC2, ORM2, OPTC, ORM1, LAMA2, WNT7A, SMOC2, SOST, FN1, C1QTNF5, COL1A1, and COL1A2 (Fig. 1D). KEGG pathway analysis identified significant enrichment in pathways in ECM-receptor interaction (P = 0.0027), including LAMA2, TNR, COMP, ITGA11, FN1, COL1A1, and COL1A2; PI3K-Akt signaling pathway (P = 0.0045), comprising LAMA2, ANGPT4, TNR, ITGA11, LPAR5, FN1, COL1A1, and COL1A2; and protein digestion and absorption (P = 0.0038), including CPB1, ATP1A2, COL7A1, COL10A1, COL5A1, COL22A1, COL1A1, and COL1A2. Differentially expressed genes and functional enrichment analysis in lens fiber cells In LFCs, we identified 2,708 differentially expressed genes between TCC patients and normal controls (|log₂ Fold Change| > 1 and P < 0.05), with 1,327 genes significantly upregulated and 1,381 downregulated. The expression patterns of these DEGs are illustrated in the hierarchical clustering heat map and volcano plot (Fig. 2A and B). The five most significantly up-regulated and down-regulated DEGs in LFCs were shown in Table 3. Fig. 2DEG analysis in lens fiber cells. (A) Heatmap of DEGs. (B) Volcano plot results of DEGs. (C) GO enrichment analysis results of DEGs. (D) Expression fold changes in RNA-seq (TCC group relative to the control group), enrichment fold changes in the lens during embryonic development from the iSyTE database, and expression level changes in the lens during embryonic development from the iSyTE database of the top 10 priority candidate genes among DEGs. (E) RT-qPCR validation results DEG analysis in lens fiber cells. (A) Heatmap of DEGs. (B) Volcano plot results of DEGs. (C) GO enrichment analysis results of DEGs. (D) Expression fold changes in RNA-seq (TCC group relative to the control group), enrichment fold changes in the lens during embryonic development from the iSyTE database, and expression level changes in the lens during embryonic development from the iSyTE database of the top 10 priority candidate genes among DEGs. (E) RT-qPCR validation results Table 3The five most significantly up-regulated and down-regulated differentially expressed genes in lens fiber cellsDifferentially expressedSymbolDescriptionLog2(fold change)P valueFDR valueDown-regulatedHOPXHOP homeobox−7.205.08E-371.90E-32MT1Hmetallothionein 1 H−5.651.80E-052.63E-03LEMD1LEM domain containing 1−5.231.60E-030.04SENP3-EIF4A1SENP3-EIF4A1 readthrough−5.045.63 E-040.03NAT1N-acetyltransferase 1−4.982.77E-081.48E-05Up-regulatedADTRPandrogen dependent TFPI regulating protein8.531.12E-111.76E-08SPON2spondin 28.466.87E-121.43E-08LGALS3BPgalectin 3 binding protein8.170.040.39NPTX2neuronal pentraxin 28.081.40E-112.02E-08HTN3histatin 37.616.65E-083.16E-05All expression fold changes were detected in the experimental group relative to the control group Table 3The five most significantly up-regulated and down-regulated differentially expressed genes in lens fiber cellsDifferentially expressedSymbolDescriptionLog2(fold change)P valueFDR valueDown-regulatedHOPXHOP homeobox−7.205.08E-371.90E-32MT1Hmetallothionein 1 H−5.651.80E-052.63E-03LEMD1LEM domain containing 1−5.231.60E-030.04SENP3-EIF4A1SENP3-EIF4A1 readthrough−5.045.63 E-040.03NAT1N-acetyltransferase 1−4.982.77E-081.48E-05Up-regulatedADTRPandrogen dependent TFPI regulating protein8.531.12E-111.76E-08SPON2spondin 28.466.87E-121.43E-08LGALS3BPgalectin 3 binding protein8.170.040.39NPTX2neuronal pentraxin 28.081.40E-112.02E-08HTN3histatin 37.616.65E-083.16E-05All expression fold changes were detected in the experimental group relative to the control group The five most significantly up-regulated and down-regulated differentially expressed genes in lens fiber cells All expression fold changes were detected in the experimental group relative to the control group GO annotation of DEGs in LFCs revealed significant enrichment in SRP-dependent cotranslational protein targeting to membrane (P < 0.001), including SRP19, SRP9, RPL39, RPS15A, RPS7, and RPL26; protein targeting to ER (P < 0.001), comprising SRP19, SRP9, RPL39, RPS15A, RPS7, and RPL26; cotranslational protein targeting to membrane (P < 0.001), including SRP19, SRP9, RPL39, RPS15A, RPS7, RPL26, RPL7, and RPL30; establishment of protein localization to endoplasmic reticulum (P < 0.001), involving CHMP4A, SRP19, SRP9, RPL39, RPS15A, and RPS7; and structural constituent of ribosome (P < 0.001), including MRPL34, MRPL13, MRPS31, MRPL36, MRPS33, MRPL32, RPL26L1, and RPL39 (Fig. 2C). KEGG pathway analysis identified significant enrichment in ribosome (P = 0.0021), comprising MRPL34, RPS10-NUDT3, MRPL13, MRPL36, MRPL32, and RPL26L1; oxidative phosphorylation (P = 0.0028), including COX7A2L, NDUFS4, COX11, UQCRB, NDUFB3, and NDUFB6; proteasome (P = 0.0034), involving PSMA2, PSMA6, PSMA4, POMP, SEM1, and PSMA3; and citrate cycle (TCA cycle) (P = 0.0031), including OGDH, SUCLG1, SDHD, FH, PC, and IDH3G. Protein-protein interaction (PPI) network analysis To explore potential functional interactions among differentially expressed proteins, we constructed PPI networks using the STRING database. Among downregulated proteins, we identified 44 proteins that connected with ≥ 4 other proteins. The top five hub proteins with the highest connectivity were ATP5O (node = 43), CCT2 (node = 43), ATP5C1 (node = 42), CCT3 (node = 40), and CCT5 (node = 39). Among upregulated proteins, 42 proteins were connected with ≥ 4 other proteins, with the top five hub proteins being ACTA2 (node = 49), ATM (node = 45), CREBBP (node = 45), CDH1 (node = 43), and CXCL8 (node = 43). These hub proteins likely play central roles in the molecular networks associated with TCC. RT-qPCR validation of RNA-seq results To validate the RNA-seq findings, we selected 7 DEGs from LECs and 9 DEGs from LFCs for RT-qPCR analysis using an independent cohort of four patients with TCC (age range: 34–57 months) and three normal controls (age range: 7–72 months). The RT-qPCR results showed 100% concordance (16/16 genes) with the RNA-seq data, confirming the reliability of our transcriptomic findings (Fig. 3). Fig. 3Validation of RNA-sequencing results by real-time quantitative PCR. (A) Real-time quantitative PCR validation of 4 up-regulated genes and 3 down-regulated genes identified by RNA-sequencing analysis in anterior lens capsule samples. (B) Real-time quantitative PCR validation of 4 up-regulated genes and 5 down-regulated genes identified by RNA-sequencing analysis in cortex and nuclear fibers. All expression fold changes were detected in the TCC group relative to the control group Validation of RNA-sequencing results by real-time quantitative PCR. (A) Real-time quantitative PCR validation of 4 up-regulated genes and 3 down-regulated genes identified by RNA-sequencing analysis in anterior lens capsule samples. (B) Real-time quantitative PCR validation of 4 up-regulated genes and 5 down-regulated genes identified by RNA-sequencing analysis in cortex and nuclear fibers. All expression fold changes were detected in the TCC group relative to the control group Identification of high-priority candidate genes through integration with the iSyTE2.0 database To prioritize candidate genes potentially associated with congenital cataract pathogenesis, we cross-referenced our DEGs with the iSyTE2.0 database. From the lens epithelial DEGs, 81 genes overlapped with the top 528 lens-enriched genes in the iSyTE2.0 Affymetrix 430 2.0 platform database. Of these 81 genes, 23 were previously reported cataract-associated genes listed in the Cat-Map database, while 58 represented novel cataract candidate genes (14 upregulated and 44 downregulated). Based on temporal expression patterns during mouse lens embryonic development (E10.5 to E16.5) from the iSyTE2.0 database, we ranked these 58 candidate genes and identified HOPX, FAM19A4, GPR160, GRIFIN, LSAMP, MATN2, SUSD2, SPON2, BHLHE41, and PYGM as the top 10 high-priority candidate genes in LECs (Fig. 1E). RT-qPCR results confirmed that HOPX, SUSD2, BIRC7, SH3BGR, and SPP1 were significantly down-regulated in TCC patients (Fig. 1F). Similarly, in LFCs, 70 DEGs overlapped with the top lens-enriched genes in the iSyTE2.0 database, comprising 22 downregulated and 48 upregulated genes. After excluding genes listed in the Cat-Map database, 53 DEGs were identified as novel candidate genes. Based on the iSyTE2.0 expression database, HOPX, SH3BGR, GSS, ARNTL2, SMCO3, BIRC7, DAPL1, MGARP, CLU, and PLA2G5 were ranked as the top 10 high-priority candidate genes in LFCs (Fig. 2D). The results of RT-qPCR validated that SH3BGR and BIRC7 were significantly down-regulated in fiber cells of TCC patients (Fig. 2E). Discussion Despite its profound impact on pediatric visual development, the pathogenesis of TCC remains incompletely characterized. This study presents a comprehensive transcriptomic analysis of LECs and LFCs from pediatric TCC patients, revealing novel molecular mechanisms underlying this condition. Through integrated RNA-seq and RT-qPCR validation, we have identified high-priority candidate genes and pathways implicated in cataract development. Our analytical workflow adhered to methodologies established by Anand et al. [22], encompassing data standardization and quality control, identification of DEGs, functional annotation and clustering, and filtering using iSyTE and Cat-Map databases. The iSyTE database, a valuable resource for visualizing spatiotemporal gene expression during lens development, enabled systematic identification of novel cataract-associated genes [23, 24]. Cross-referencing DEGs with the iSyTE2.0 database prioritized five genes (HOPX, SUSD2, SH3BGR, BIRC7, GSS) with plausible mechanistic links to cataract formation. Notably, HOPX exhibited the most pronounced downregulation among high-priority candidate genes in both LECs and LFCs. HOPX belongs to the homeobox gene family that encodes transcription factors crucial for controlling cell differentiation and developmental processes [25]. While HOPX regulates critical biological processes in embryonic/adult stem cells across tissues [26], its specific role in lens development and cataract formation remains unclear. The significant downregulation of HOPX in both cell types suggests a potential role in lens development, possibly through regulation of cellular differentiation, oxidative stress response, calcium handling, or metabolic function [27, 28]. Future functional studies are warranted to investigate how HOPX downregulation contributes to cataract formation. SUSD2, markedly downregulated in both LECs and LFCs, encodes a transmembrane protein enriched in placental stromal cells that co-localize with perivascular markers (e.g., α-SMA) [29]. SUSD2 is involved in mesenchymal cell differentiation and tissue repair processes. While its precise function in the lens remains unknown, its role in stem cell differentiation and intercellular interactions suggests potential involvement in regulating LECs or fibrotic processes that may contribute to cataract formation. SH3BGR, also downregulated in both lens compartments, contains an SH3 domain and primarily functions in cell signaling and cytoskeletal regulation. Previous studies have reported significant downregulation of SH3BGR in LECs of cataractous lenses [30] and in aged LFCs [31]. This consistent finding across multiple studies strengthens the evidence for SH3BGR’s involvement in cataract pathogenesis. Oxidative stress, a major contributor to cataract formation, may dysregulate SH3BGR expression, promoting apoptotic imbalance and cataract acceleration [32]. BIRC7, significantly downregulated in both lens cell types in our study, has been previously identified as a late fiber gene strongly upregulated in deep cortical fiber cells [33]. As a member of the Inhibitor of Apoptosis Protein family, BIRC7’s primary function is to inhibit apoptosis. In the lens, BIRC7 expression is regulated by Pax6, and during stress-induced cataract formation, altered Pax6 expression can disrupt the expression of apoptosis-related genes like BIRC7, potentially promoting cataract development through dysregulated lens cell apoptosis [34]. GSS encodes a key enzyme in glutathione synthesis, crucial for maintaining redox balance in the lens [35]. Glutathione plays a vital role in protecting lens proteins from oxidative damage, and its depletion has been associated with cataract formation [36]. The altered expression of GSS observed in our study may contribute to oxidative stress and subsequent protein aggregation in the lens, ultimately leading to opacity. This finding aligns with the well-established role of oxidative stress in cataract pathogenesis [37] and suggests potential therapeutic approaches targeting antioxidant pathways. Our analysis also identified several other candidate genes with potential roles in cataract formation. SLC7A5, encoding an amino acid transporter, may contribute to cataract development through mechanisms involving impaired amino acid transport [38], oxidative stress [39], cell apoptosis [40], or inflammation [41]. FAM46C, with potential regulatory roles in apoptosis and oxidative stress, and PCP4, involved in AKT and AMPK pathway regulation, represent additional candidates worthy of further investigation. The diverse functions of these candidate genes reflect the complex, multifactorial nature of congenital cataract pathogenesis. Our findings suggest several potential mechanisms contributing to lens opacity, including disruption of lens development and differentiation, oxidative stress and altered redox homeostasis, dysregulation of protein metabolism and quality control, and abnormal cell survival and apoptosis regulation. These pathways likely interact in complex ways to influence lens transparency and may represent targets for therapeutic intervention. The identification of distinct transcriptomic profiles in LECs and LFCs provides a comprehensive view of TCC pathogenesis. In LECs, dysregulation of structural proteins (e.g., CRYBA1) and ECM components (e.g., COL1A1) aligns with their role in maintaining lens capsule integrity and epithelial-mesenchymal interactions, while crystallin downregulation suggests compromised transparency. Conversely, LFCs exhibited pronounced disruption in ribosomal and oxidative phosphorylation genes (e.g., MRPL34, NDUFS4), reflecting their high metabolic demand for protein synthesis and energy production during terminal differentiation. This compartment-specificity implies that targeted therapies may be necessary, addressing pathways like ECM remodeling in LECs and mitochondrial function in LFCs. Our PPI network analysis identified several hub proteins, including ATP5O, CCT2, ATP5C1, CCT3, and CCT5 among downregulated proteins, and ACTA2, ATM, CREBBP, CDH1, and CXCL8 among upregulated proteins. These hub proteins, characterized by high connectivity within the networks, likely play central roles in the molecular pathways underlying TCC. For example, ATP5O and ATP5C1 are components of the mitochondrial ATP synthase complex involved in oxidative phosphorylation, suggesting potential metabolic dysregulation in cataractous lenses. The CCT family proteins are molecular chaperones that assist in protein folding, consistent with the enrichment of protein-related pathways in our functional analyses. ACTA2, encoding α-smooth muscle actin, is a marker of epithelial-mesenchymal transition, which has been implicated in certain forms of cataracts. These findings provide a foundation for further investigation into the complex molecular networks involved in cataract development. Our findings hold notable clinical implications. The identification of novel candidate genes expands the spectrum of potential genetic causes for TCC, which may enhance genetic screening and diagnosis. Understanding the molecular pathways involved in cataract formation could lead to the development of targeted therapeutic approaches aimed at preventing or delaying cataract progression. For instance, antioxidant-based therapies targeting GSS-mediated pathways or interventions modulating BIRC7-regulated apoptosis might represent promising strategies for certain cases of congenital cataract. Nevertheless, this study has several limitations. First, the small cohort size (n = 4) with minor age differences limits the generalizability of our findings and positions this study as hypothesis-generating, as it may have precluded the detection of more subtle gene expression changes. Second, while RNA-seq provides a comprehensive view of transcriptomic alterations, it does not capture post-transcriptional modifications, protein-level changes, or epigenetic factors that may influence cataract development. Third, despite collection within 24 h, the use of postmortem control samples might introduce confounding variables. Finally, our analysis focused on differential expression patterns without directly addressing causality, and functional studies are needed to validate the roles of the identified candidate genes. Despite these limitations, our findings have potential implications for clinical practice. First, the identified candidate genes may serve as novel biomarkers for cataract diagnosis, potentially expanding current genetic testing panels and improving genetic counseling accuracy. Second, the molecular pathways uncovered in this study could represent future targets for pharmacological intervention. Although surgery remains the standard of care, a better understanding of the molecular mechanisms underlying cataract formation may ultimately inform the development of targeted preventive strategies, particularly for early intervention in TCC patients. In this comprehensive transcriptomic analysis of lens tissue from children with TCC, we identified distinct gene expression patterns in LECs and fiber cells and uncovered several novel candidate genes potentially involved in cataract pathogenesis. Our findings highlight multiple molecular mechanisms that may contribute to lens opacity, including dysregulation of lens development, oxidative stress response, protein metabolism, and apoptosis regulation. Through bioinformatic analysis and cross-referencing with the iSyTE2.0 database, we identified HOPX, SUSD2, SH3BGR, BIRC7, and GSS as high-priority candidate genes consistently dysregulated in both LECs and fiber cells. These genes participated in essential biological mechanisms, such as transcriptional regulation, cell differentiation, oxidative stress response, apoptosis inhibition, and glutathione synthesis. The altered expression of these genes may contribute to lens opacity through disruption of lens development, protein homeostasis, redox balance, and cell survival. Conclusions Our findings provide new insights into the molecular mechanisms underlying TCC and expand the catalog of candidate genes for future genetic screening. The identification of these differentially expressed genes suggests potential therapeutic targets for intervention strategies. Future studies should focus on validating the functional roles of these candidate genes in lens development and cataract formation using appropriate model systems. Additionally, investigating the interactions between these genes and known cataract-causing genes may further elucidate the complex pathways involved in congenital cataract. Supplementary Information Supplementary file 1. Supplementary file 1.